IMC Chicago’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $272K | Sell |
50,300
-21,900
| -30% | -$131K | ﹤0.01% | 4707 |
|
|
2025
Q4 | $502K | Buy |
72,200
+14,200
| +24% | +$93.4K | ﹤0.01% | 3477 |
|
|
2025
Q3 | $374K | Sell |
58,000
-5,700
| -9% | -$39K | ﹤0.01% | 3329 |
|
|
2025
Q2 | $424K | Buy |
63,700
+13,700
| +27% | +$70.4K | ﹤0.01% | 2952 |
|
|
2025
Q1 | $324K | Sell |
50,000
-14,400
| -22% | -$103K | ﹤0.01% | 2887 |
|
|
2024
Q4 | $519K | Sell |
64,400
-24,000
| -27% | -$198K | ﹤0.01% | 2735 |
|
|
2024
Q3 | $721K | Sell |
88,400
-16,500
| -16% | -$109K | ﹤0.01% | 2219 |
|
|
2024
Q2 | $731K | Sell |
104,900
-74,200
| -41% | -$561K | ﹤0.01% | 2126 |
|
|
2024
Q1 | $1.9M | Buy |
179,100
+38,700
| +28% | +$338K | ﹤0.01% | 1390 |
|
|
2023
Q4 | $1.13M | Buy |
140,400
+66,300
| +89% | +$483K | ﹤0.01% | 1392 |
|
|
2023
Q3 | $609K | Sell |
74,100
-14,300
| -16% | -$123K | ﹤0.01% | 1371 |
|
|
2023
Q2 | $707K | Buy |
88,400
+12,700
| +17% | +$93.6K | ﹤0.01% | 1128 |
|
|
2023
Q1 | $613K | Sell |
75,700
-16,200
| -18% | -$130K | ﹤0.01% | 1142 |
|
|
2022
Q4 | $577K | Sell |
91,900
-64,500
| -41% | -$450K | ﹤0.01% | 1118 |
|
|
2022
Q3 | $1.08M | Sell |
156,400
-12,300
| -7% | -$85.4K | ﹤0.01% | 908 |
|
|
2022
Q2 | $1.41M | Buy |
168,700
+74,000
| +78% | +$1.03M | ﹤0.01% | 764 |
|
|
2022
Q1 | $2.16M | Buy |
94,700
+41,600
| +78% | +$1.02M | ﹤0.01% | 760 |
|
|
2021
Q4 | $1.47M | Sell |
53,100
-41,700
| -44% | -$1.12M | ﹤0.01% | 890 |
|
|
2021
Q3 | $2.64M | Sell |
94,800
-14,400
| -13% | -$408K | ﹤0.01% | 782 |
|
|
2021
Q2 | $3.2M | Sell |
109,200
-16,300
| -13% | -$494K | ﹤0.01% | 675 |
|
|
2021
Q1 | $3.98M | Buy |
125,500
+30,400
| +32% | +$892K | 0.01% | 614 |
|
|
2020
Q4 | $1.98M | Buy |
95,100
+3,300
| +4% | +$61.6K | ﹤0.01% | 732 |
|
|
2020
Q3 | $1.43M | Buy |
91,800
+1,200
| +1% | +$20.7K | ﹤0.01% | 651 |
|
|
2020
Q2 | $1.66M | Sell |
90,600
-57,100
| -39% | -$1.01M | ﹤0.01% | 598 |
|
|
2020
Q1 | $2.29M | Sell |
147,700
-80,200
| -35% | -$1.93M | ﹤0.01% | 480 |
|
|
2019
Q4 | $6.82M | Buy |
227,900
+52,900
| +30% | +$1.38M | 0.02% | 293 |
|
|
2019
Q3 | $3.82M | Buy |
175,000
+51,700
| +42% | +$1.18M | 0.01% | 338 |
|
|
2019
Q2 | $3.11M | Sell |
123,300
-22,300
| -15% | -$529K | 0.01% | 352 |
|
|
2019
Q1 | $3.6M | Sell |
145,600
-95,400
| -40% | -$2.28M | 0.01% | 285 |
|
|
2018
Q4 | $4.45M | Buy |
+241,000
| New | +$5.73M | 0.01% | 225 |
|
Other funds holding BHC
PC
GAM
VCM
MP
KKRC
IMC Chicago's BHC Position: Q4 2024 in Review
IMC Chicago sold out of Bausch Health (BHC) in Q4 2024, closing a stake of 27,668 shares — an estimated $228K sold.
IMC Chicago first reported a position in BHC in Q4 2018 and held it in 12 quarters. The position peaked at $1.06M in Q1 2022. 225 funds tracked by Wall St. Rank hold BHC as of Q4 2024.
- IMC Chicago reported no remaining Bausch Health position as of Q4 2024 after selling out during the quarter.
- IMC Chicago sold 27,668 Bausch Health shares in Q4 2024, an estimated $228K.
- IMC Chicago first reported a position in Bausch Health in Q4 2018 and held it in 12 quarters.
- IMC Chicago's Bausch Health position peaked at $1.06M in Q1 2022.
- 225 funds tracked by Wall St. Rank held Bausch Health as of Q4 2024.
Based on IMC Chicago's 13F filing for Q4 2024, filed 27 Jan 2025.